Neostellar Capital Corp. — Form 8-K

Neostellar's NAV per share declined from $13.44 (June 30, 2026) to $12.64 (September 30, 2026), a 5.96% quarterly drop. The company formalized its partnership with Magnetar through Neostellar Advisors LLC and received $20.0 million in redeemable promissory notes at 6.50% due July 2029. Q3 saw a net realized loss of $7.7 million, unrealized depreciation of $9.4 million, and new investment of $0.1 million (warrant exercise). Portfolio fair value stands at $377.2 million across 34 companies; top 5 holdings (Whoop 38%, ARK/OpenAI 15.8%, IH10/VAST 9%, Magnetar/TensorWave 5.4%, Blink Health 3.5%) represent 72% of portfolio. Share repurchase program extended with $25 million remaining authorization through October 2027.